tradingkey.logo

Abbvie Inc Reports $823 Million IPR&D And Milestones Expense For Q2 2025

ReutersJul 3, 2025 5:34 PM

- Abbvie Inc ABBV.N:

  • ABBVIE INC - REPORTS $823 MILLION IPR&D AND MILESTONES EXPENSE FOR Q2 2025 - SEC FILING

  • ABBVIE INC - EXPENSE IMPACTS Q2 GAAP AND NON-GAAP EPS BY $0.42 - SEC FILING

  • ABBVIE INC - 2025 ADJUSTED EPS GUIDANCE RANGE IS $11.67 - $11.87 - SEC FILING

  • ABBVIE INC - Q2 2025 ADJUSTED EPS GUIDANCE RANGE IS $2.84 - $2.88 - SEC FILING

Source text: [ID:n0001551152-25-000034]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI